Scientific paper - Original scientific paper
More Pronounced Muscle Loss During Immunochemotherapy is Associated with Worse Clinical Outcomes in Newly Diagnosed Patients with Diffuse Large B-Cell Lymphoma with Unfavorable Features
Therapeutics and Clinical Risk Management, 17 (2021); 1037-1044. https://doi.org/10.2147/TCRM.S323749


Cite this document

Lucijanić, M., Huzjan Korunić, R., Sedinic, M., Kušec, R. & Pejša, V. (2021). More Pronounced Muscle Loss During Immunochemotherapy is Associated with Worse Clinical Outcomes in Newly Diagnosed Patients with Diffuse Large B-Cell Lymphoma with Unfavorable Features. Therapeutics and Clinical Risk Management, 17., 1037-1044. doi: 10.2147/TCRM.S323749

Lucijanić, Marko, et al. "More Pronounced Muscle Loss During Immunochemotherapy is Associated with Worse Clinical Outcomes in Newly Diagnosed Patients with Diffuse Large B-Cell Lymphoma with Unfavorable Features." Therapeutics and Clinical Risk Management, vol. 17, 2021, pp. 1037-1044. https://doi.org/10.2147/TCRM.S323749

Lucijanić, Marko, Renata Huzjan Korunić, Martina Sedinic, Rajko Kušec and Vlatko Pejša. "More Pronounced Muscle Loss During Immunochemotherapy is Associated with Worse Clinical Outcomes in Newly Diagnosed Patients with Diffuse Large B-Cell Lymphoma with Unfavorable Features." Therapeutics and Clinical Risk Management 17 (2021): 1037-1044. https://doi.org/10.2147/TCRM.S323749

Lucijanić, M., et al. (2021) 'More Pronounced Muscle Loss During Immunochemotherapy is Associated with Worse Clinical Outcomes in Newly Diagnosed Patients with Diffuse Large B-Cell Lymphoma with Unfavorable Features', Therapeutics and Clinical Risk Management, 17, pp. 1037-1044. doi: 10.2147/TCRM.S323749

Lucijanić M, Huzjan Korunić R, Sedinic M, Kušec R, Pejša V. More Pronounced Muscle Loss During Immunochemotherapy is Associated with Worse Clinical Outcomes in Newly Diagnosed Patients with Diffuse Large B-Cell Lymphoma with Unfavorable Features. Therapeutics and Clinical Risk Management [Internet]. 2021 September 24 [cited 2024 February 29];17:1037-1044. doi: 10.2147/TCRM.S323749

M. Lucijanić, R. Huzjan Korunić, M. Sedinic, R. Kušec and V. Pejša, "More Pronounced Muscle Loss During Immunochemotherapy is Associated with Worse Clinical Outcomes in Newly Diagnosed Patients with Diffuse Large B-Cell Lymphoma with Unfavorable Features", Therapeutics and Clinical Risk Management, vol. 17, pp. 1037-1044, September 2021. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:931158. [Accessed: 29 February 2024]

Please login to the repository to save this object to your list.